Chinese Journal of Integrative Medicine

, Volume 14, Issue 1, pp 56–60 | Cite as

Clinical observation on trigonella foenum-graecum L. total saponins in combination with sulfonylureas in the treatment of type 2 diabetes mellitus

  • Fu-rong Lu (卢芙蓉)
  • Lin Shen (沈霖)
  • You Qin (秦铀)
  • Lan Gao (高兰)
  • Heng Li (李恒)
  • Yi Dai (戴燚)
Clinical Experience



To evaluate the efficacy and safety of trigonella foenum-graecum L. total saponins (TFGs) in combination with sulfonylureas (SU) in the treatment of patients with type 2 diabetes mellitus (T2DM) not well controlled by SU alone.


Sixty-nine T2DM patients whose blood glucose levels were not well controlled by oral sulfonylureas hypoglycemic drug were randomly assigned to the treated group (46 cases) and the control group (23 cases), and were given TFGs or placebo three times per day, 6 pills each time for 12 weeks, respectively. Meanwhile, the patients continued taking their original hypoglycemic drugs. The following indexes, including effects on traditional Chinese medicine (TCM) symptoms, fast blood glucose (FBG), 2-h post-prandial blood glucose (2h PBG), glycosylated hemoglobin (HbA1c), clinical symptomatic quantitative scores (CSQS), body mass index (BMI), as well as hepatic and renal functions, were observed and compared before and after treatment.


The efficacy on TCM symptoms was obviously better in the treated group than that in the control group (P<0.01), and there were statistically remarkable decreases in aspect of FBG, 2h PBG, HbA1c and CSQS in the treated group as compared to those in the control group (P<0.05 or P<0.01), while no signifiClassifi cationcant difference was found in BMI, hepatic and renal functions between the two groups (P>0.05).


The combined therapy of TFGs with sulfonylureas hypoglycemic drug could lower the blood glucose level and ameliorate clinical symptoms in the treatment of T2DM, and the therapy was relatively safe.

Key Words

trigonella foenum-graecum L. type 2 diabetes mellitus sulfonylureas 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Pan CY, Jin WS. Epidemiology of type 2 diabetes mellitus. Chin J Endocrinol Metab (Chin) 2005;21(5):5S1–5S5.Google Scholar
  2. 2.
    Xu MY, Lu GH, Chen MD, eds. Diabetes. Shanghai: Shanghai Scientific and Technical Publishers, 2003:304–305.Google Scholar
  3. 3.
    Neeraja A, Rajyalakshmi P. Hypoglycemic effect of processed fenugreek seed in humans. J Food Sci Technol 1996;33:427–431.Google Scholar
  4. 4.
    The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1057–1058.Google Scholar
  5. 5.
    The Special Committee of Diabetes Mellitus, Chinese Association of the Integration of Traditional and Western Medicine. Standard for Diagnosis and Therapeutic Effect Evaluation of Diabetes Mellitus by Integrative Chinese and Western Medicine (Draft, Chin). Chin J Integr Med 2005;25(1):94–95.Google Scholar
  6. 6.
    Ministry of Health, P. R. China. Guiding Principle of Clinical Research on New Drugs of TCM. Vol 1. Beijing: People’s Medical Publishing House, 1993:215–217.Google Scholar
  7. 7.
    Ferrannini E. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Rev 1998;19:477–490.PubMedCrossRefGoogle Scholar
  8. 8.
    Sharma RD, Sarkar A, Hazra DK, et al. Use of fenugreek seed powder in the management of non-insulin dependent diabetes mellitus. Nutrit Res 1996;16:1331–1339.CrossRefGoogle Scholar
  9. 9.
    Li LL, Zhang YM, Wang XF, et al. The study of TFGs extracts on type 2 diabetes mellitus mice and rats. J Xinjiang Med Univ (Chin) 2005;28(2):98–101.Google Scholar
  10. 10.
    Ravtkumar P, Anuradha CV. Effect of fenugreek seeds on blood lipid peroxidation and antioxidants in diabetic rats. Phytother Res 1999;13(3):197–201.CrossRefGoogle Scholar
  11. 11.
    Preet A, Siddiqui MR, Taha A, et al. Long-term effect of Trigonella foenum graecum and its combination with sodium orthovanadate in preventing histopathological and biothemical abnormalities in diabetic rat ocular tissues. Mol Cell Biochem 2006;289:137–147.PubMedCrossRefGoogle Scholar
  12. 12.
    Thakran S, Siddiqui MR, Baquer NZ. Trigonella foenum graecum seed powder protects against pathological abnormalities in tissues of diabetic rats. Mol Cell Biochem 2004;266:151–159.PubMedCrossRefGoogle Scholar
  13. 13.
    Vijayakumar MV, Singh S, Chhipa RR. The hypoglycaemic activity of fenugreek seed extract is mediated through the stimulation of an insulin signalling pathway. Br J Pharmacol 2005;146:41–48.PubMedCrossRefGoogle Scholar

Copyright information

© Chinese Association of the Integration of Traditional and Western Medicine and Springer-Verlag GmbH 2008

Authors and Affiliations

  • Fu-rong Lu (卢芙蓉)
    • 1
  • Lin Shen (沈霖)
    • 1
  • You Qin (秦铀)
    • 1
  • Lan Gao (高兰)
    • 1
  • Heng Li (李恒)
    • 1
  • Yi Dai (戴燚)
    • 1
  1. 1.Department of Integrated Chinese and Western Medicine, Union Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina

Personalised recommendations